I can only agree with the request to speak. In
Post# of 36536
In the past, promises were constantly not kept or later no mention was made of why this is so.
For me the last 3 messages unfortunately still show no meat, they indicate that meat is in prospect, but nothing more.
So this year, in my opinion, there is no significant income to be expected. The Excel syringes sell a maximum of 1000 in 1 year, which would be around $ 1 million. The approval is still pending from the FDA in Malaysia and a promising investor who is securing the funds for the production is already there, but not quite ... great
The peanut amounts of 2 million from China might have been worth mentioning 30 years ago, but today this is comparable to 200TSD.
Continuous dilution does not take place in vain.
From approx. 70 million to currently 117 million.
The IPO of NGIO, which was supposed to take place in March oh sorry then April, didn't even find space in the advance notice on the CC and recently these great papers can only be sold after 90 days. Man oh man...
The financial injections that should be released by the IPO are therefore not in sight.
And the nonsense about the quiet phase, you could perhaps tell an investor 50 years ago. But it looks like we're celebrating one year old soon.
See your conclusions after the CC tomorrow as I will.
This share is pure money destruction and the chances on the market are left behind ...